| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-82-1-27 |
| P698 | PubMed publication ID | 1235758 |
| P2093 | author name string | I. Nyarai | |
| K. G. Dawson | |||
| L. Wallach | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | internal medicine | Q11180 |
| hypertension | Q95566669 | ||
| P304 | page(s) | 27-34 | |
| P577 | publication date | 1975-01-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Stimulated renin: a screening test for hypertension | |
| Stimulated Renin: A Screening Test for Hypertension | |||
| P478 | volume | 82 |
| Q40173254 | Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs on the Kidney |
| Q39724832 | Clinical Relevance of Plasma Renin Activity in Hypertensive Patients |
| Q41763745 | Clinical value of plasma renin determinations in renovascular and primary hypertension |
| Q58769018 | Controlling resistant hypertension |
| Q39138647 | Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension |
| Q38622100 | Differential diagnosis and management of renovascular hypertension through nuclear medicine techniques |
| Q40599090 | Effect of antihypertensive drugs on the renin-angiotensin system |
| Q34449171 | Effect of chronic diuretic treatment on the plasma renin-angiotensin-aldosterone system in essential hypertension |
| Q88550264 | Effects of Eplerenone on Resistance to Antihypertensive Medication in Patients with Primary or Secondary Hyperaldosteronism |
| Q45108078 | Furosemide Stimulation of Peripheral Renin in Men and Women |
| Q44258056 | Hormonal effects of the diuretic xipamide in healthy men |
| Q70940694 | Human plasma vasopressin response to potent loop-diuretic drugs |
| Q37215333 | Intensive risk factor control in stroke prevention |
| Q90340474 | Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs |
| Q28317982 | Low renin hypertension. A distinct entity |
| Q58770725 | New treatment options for hypertension during acute ischemic or hemorrhagic stroke |
| Q35815329 | Pheochromocytoma presenting with pulmonary edema and hyperamylasemia |
| Q41451761 | Physiologic tailoring of treatment in resistant hypertension |
| Q72843851 | Pindolol in the treatment of hypertension: Systolic time intervals as a predictor of response to beta receptor blockade |
| Q57086029 | Plasma atrial natriuretic peptide and the renin-aldosterone system during long-term administration of the diuretic xipamide in man |
| Q67562641 | Plasma concentrations of propranolol in patients with essential hypertension |
| Q39662616 | Plasmatic renin activity in patients treated with l-dopa and inhibitor of dopa decarboxylase (IDC) |
| Q67406488 | Reduced renin activity in essential hypertension: a reappraisal |
| Q41695185 | Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl) |
| Q44871943 | Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects |
| Q38050943 | Renin-angiotensin system in hypertension |
| Q37778989 | Secondary stroke prevention. |
| Q67319389 | Solitary intrarenal cyst: Correctable cause of hypertension |
| Q34103548 | Stepped care for hypertension is dead, but what will replace it? |
| Q68212869 | Stimulation of renin secretion by various methods: optional results with hydrochlorothiazide |
| Q37103842 | The Adrenal Cortex and Essential Hypertension |
| Q37045514 | Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake |
Search more.